Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
02:30:02 03/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 93.26 USD | +1.36% |
|
+2.98% | +9.40% |
| 09:00am | Edwards Lifesciences Corporation - Special Call | |
| 03/11 | Edwards Lifesciences Says TAVR Superior to Surveillance in Moderate Aortic Stenosis Trial | MT |
| Market Cap | 5.38TCr 4.8TCr 4.4TCr 4.01TCr 7.51TCr 5,08900Cr 7.66TCr 53TCr 21TCr 2,68600Cr 20TCr 20TCr 8,48400Cr | P/E 2026 * |
37x | P/E 2027 * | 28.3x |
|---|---|---|---|---|---|
| Enterprise Value | 5.01TCr 4.48TCr 4.11TCr 3.74TCr 7TCr 4,74500Cr 7.14TCr 49TCr 20TCr 2,50500Cr 19TCr 18TCr 7,91100Cr | EV / Sales 2026 * |
7.41x | EV / Sales 2027 * | 6.53x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Tradegate
| EWL | Real-time | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Xetra
| EWL | Delayed | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +1.36% | ||
| 1 week | +2.98% | ||
| Current month | +1.36% | ||
| 1 month | +9.52% | ||
| 3 months | +8.35% | ||
| 6 months | +11.05% | ||
| Current year | +9.40% |
| 1 week | 87.9 |  | 95.75 |
| 1 month | 82.42 | | 95.75 |
| Current year | 74.66 | | 96.29 |
| 1 year | 74.66 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/10/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 14/09/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 13/09/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.36% | +2.98% | +13.11% | +42.32% | 5.38TCr | |
| -2.06% | -0.33% | +20.31% | +52.52% | 25TCr | |
| -1.83% | -2.15% | +5.85% | +18.13% | 16TCr | |
| +1.12% | -3.27% | -18.23% | +57.21% | 15TCr | |
| +5.57% | -2.76% | -56.00% | -15.61% | 6.42TCr | |
| +0.06% | +3.85% | -10.94% | -9.38% | 5.41TCr | |
| -1.90% | -3.51% | +5.43% | +61.66% | 4.97TCr | |
| -1.65% | -2.26% | +17.51% | +64.63% | 4.85TCr | |
| -2.85% | -1.41% | +28.58% | +83.18% | 4.42TCr | |
| -3.99% | -16.40% | +83.41% | +101.84% | 3.43TCr | |
| Average | +0.12% | -2.33% | +8.90% | +45.65% | 9.13TCr | |
| Weighted average by Cap. | -0.44% | -1.34% | +5.55% | +42.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 676.11Cr 603.63Cr 553.92Cr 503.88Cr 944.7Cr 64TCr 963.52Cr 6.62TCr 2.67TCr 34TCr 2.54TCr 2.48TCr 1,06700Cr | 743.08Cr 663.43Cr 608.79Cr 553.79Cr 1.04TCr 70TCr 1.06TCr 7.27TCr 2.93TCr 37TCr 2.79TCr 2.73TCr 1,17300Cr |
| Net income | 145.84Cr 130.21Cr 119.48Cr 108.69Cr 203.78Cr 14TCr 207.84Cr 1.43TCr 575.27Cr 7.29TCr 547.36Cr 535.69Cr 23TCr | 188.18Cr 168.01Cr 154.17Cr 140.24Cr 262.93Cr 18TCr 268.17Cr 1.84TCr 742.27Cr 9.4TCr 706.25Cr 691.2Cr 30TCr |
| Net Debt | -363.09Cr -324.16Cr -297.47Cr -270.59Cr -507.33Cr -34TCr -517.44Cr -3.55TCr -1.43TCr -18TCr -1.36TCr -1.33TCr -57TCr | -519.47Cr -463.78Cr -425.59Cr -387.14Cr -725.83Cr -49TCr -740.29Cr -5.08TCr -2.05TCr -26TCr -1.95TCr -1.91TCr -82TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $93.26 | +1.36% | 1,21,72,521 |
| 30/26/30 | $92.01 | -2.57% | 60,44,702 |
| 29/26/29 | $94.44 | +2.90% | 46,80,786 |
| 28/26/28 | $91.78 | +1.06% | 22,96,758 |
| 27/26/27 | $90.82 | +0.29% | 30,20,207 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
